Katherine A. High

Leave a Comment / Gene therapy, Transhumanism / By

Katherine A. High is an American doctor who is an Emeritus Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania . She is currently the President and Chief Scientific Officer of Spark Therapeutics . High earned at AB in chemistry at the Harvard College in 1972 and a MD in 1978 at the University of North Carolina School of Medicine . She did her training in hematology with Edward J. Benz, Jr. at Yale University . [1]

Her work is focused on the use of gene therapy for hemophilia. She was the director of the Center for Cellular and Molecular Therapeutics at the Children’s Hospital of Philadelphia and an investigator of the Howard Hughes Medical Institute . [2] [3] High is a member of the Institute of Medicine and a fellow of the American Academy of Arts and Sciences

References

  1. Jump up^ Wilson, James M. (1 December 2016). “Interview with Katherine A. High, MD” . Human Gene Therapy Clinical Development . 27 (4): 127-131. doi : 10.1089 / humc.2016.29021.int . ISSN  2324-8637 . Retrieved 1 October 2017 .
  2. Jump up^ “Katherine High” (PDF) . Retrieved 1 October 2017 .
  3. Jump up^ “Katherine A. High, MD – IHG Symposium 2015” . IHG Symposium 2015 . September 1, 2015 . Retrieved 1 October 2017 .

Related posts:

  1. Gene therapy Gene therapy is the therapeutic delivery of nucleic acid in a patient’s cells as a drug to treat disease. [1] The first attempt at human-modifying DNA Was Performed in 1980 by Martin Cline , drank the first successful nuclear gene transfer in humans, approved by the National Institutes of Health , Was Performed in May 1989. [2] The first therapeutic use of gene transfer as...
  2. Gene therapy of the human retina Retinal gene therapy holds great promise in treating different forms of non-inherited and inherited blindness ....
  3. Gene therapy for osteoarthritis Gene transfer strategies for medical management of osteoarthritis have attracted the attention of scientists to the complex pathology of this chronic disease. Unlike other pharmacological treatments, gene therapy targets the disease process rather than the symptoms. [1]...
  4. Designer baby A designer is a human embryo that has been genetically modified , usually following guidelines set by the parent or scientist, to produce desirable traits. This is done using various methods, such as gene therapy or Preimplantation genetic diagnosis (PGD). This technology is the subject of ethical debate, bringing up the concept of genetically modified “superhumans” to replace modern humans....
  5. Gene therapy for color blindness Gene therapy for color blindness is an experimental gene therapy aiming to convert congenitally colorblinds to trichromats by introducing a photopigment gene that they lack. Though partial color blindness is considered to be a disadvantage, it is a condition that affects many people, particularly males . Complete color blindness, or achromatopsia , is very rare but more severe. While never shown in humans, animal studies have...
  6. Bioviva BioViva is a Bainbridge Island, Washington- based biotechnology company developing treatments to slow the aging process in humans....
  7. Gene therapy in Parkinson’s disease Gene therapy in Parkinson’s disease is a specific neurotransmitter ( dopamine ), protect the neural system, or the modification of genes that are related to the disease. Then these cells are transplanted to a patient with the disease. There are different kinds of treatments that focus on reducing the symptoms of the disease but there...
  8. Martine Rothblatt Martine Aliana Rothblatt (born 1954) is an American lawyer, author, and entrepreneur. Rothblatt graduated from University of California, Los Angeles with a combined law and MBA degree in 1981, then began work in Washington, DC , first in the field of satellite communications law, and eventually in life sciences projects like the Human Genome Project . [5] She is the founder and...
  9. CP Dunphey Charles Patrick Dunphey (born November 22, 1992) is an American author from Staten Island, New York who lives in southern Mississippi . His early work, a science fiction horror novel titled Plane Walker , Was released in April 2016. Dunphey est aussi a movie reviewer , [1] and founder of Hinnom Gehenna and Books....
  10. Voretigene neparvovec Voretigene neparvovec ( Luxturna ) is a novel gene therapy for the treatment of Leber’s congenital amaurosis . It was developed by Spark Therapeutics and Children’s Hospital of Philadelphia . [1] [2] It is the first in vivo gene therapy approved by the FDA. [3]...

Leave a Comment

Your email address will not be published. Required fields are marked *